ARVN - Arvinas: 2022 Is Full Of Catalysts For This Protein Degrader Pioneer
- Arvinas was founded by Dr. Craig Crews, the pioneer in the field of targeted protein degradation.
- ARVN has a mega deal with Pfizer.
- It has a slew of catalysts in 2022 that should impact the stock positively.
For further details see:
Arvinas: 2022 Is Full Of Catalysts For This Protein Degrader Pioneer